Skip to main content

Table 3 Performance of careHPV and genotyping to detect cases of cytological abnormalities (LSIL and greater, n = 8) among 197 study participants in Cape Coast, Ghana

From: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana

Performance Indicators

careHPV

% (95%CI)

Anyplex II HPV 28

% (95%CI)

Number of LSIL+ cases detected by assay

7

7

Sensitivity

87.5 (47.3–99.7)

87.5 (47.3–99.7)

Specificity

52.1 (44.7–59.5)

38.8 (31.8–46.2)

Positive predictive value (PPV)

7.2 (3.0–14.3)

5.7 (2.3–11.5)

Negative predictive value (NPV)

99.0 (94.5–100.0)

98.6 (92.7–100.0)